The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, Guy M., Knopman, David S., Chertkow, Howard, Hyman, Bradley T., Jack, Clifford R., Kawas, Claudia H., Klunk, William E., Koroshetz, Walter J. +10 more·2011·Alzheimer's & Dementia

Cited by (1,513)

Items 301–400 of 1,513

  1. The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
    Joel Simrén, Antoine Leuzy, Thomas K. Karikari, Abdul Hye, Andréa Lessa Benedet, Juan Lantero‐Rodriguez, Niklas Mattsson, Michael Schöll, Patrizia Mecocci, Bruno J. Vellas et al. · 2021 · Alzheimer s & Dementia
  2. Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease
    Luke Whiley, Arundhuti Sen, James C. Heaton, Petroula Proitsi, Diego García‐Gómez, Rufina Leung, Norman William Smith, Madhav Thambisetty, Iwona Kłoszewska, Patrizia Mecocci et al. · 2013 · Neurobiology of Aging
  3. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease
    Lehmann, Manja, Ghosh, Pia M., Madison, Cindee, Laforce, Robert, Corbetta-Rastelli, Chiara, Weiner, Michael W., Greicius, Michael D., Seeley, William W., Gorno-Tempini, Maria L., Rosen, Howard J. et al. · 2013 · Brain
  4. Astrocyte Biomarkers in Alzheimer’s Disease
    Carter, Stephen F., Herholz, Karl, Rosa-Neto, Pedro, Pellerin, Luc, Nordberg, Agneta, Zimmer, Eduardo R. · 2019 · Trends in Molecular Medicine
  5. Brain Glutathione Levels – A Novel Biomarker for Mild Cognitive Impairment and Alzheimer’s Disease
    Pravat Kumar Mandal, Sumiti Saharan, Manjari Tripathi, Geetanjali Murari · 2015 · Biological Psychiatry
  6. Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention
    Francesco Panza, Madia Lozupone, Vincenzo Solfrizzi, Rodolfo Sardone, Vittorio Dibello, Luca Di Lena, Francesca D’Urso, Roberta Stallone, Massimo Petruzzi, Gianluigi Giannelli et al. · 2018 · Journal of Alzheimer s Disease
  7. The degree of frailty as a translational measure of health in aging
    Susan Ellen Howlett, Andrew D. Rutenberg, Kenneth J. Rockwood · 2021 · Nature Aging
  8. Clinicopathologic and<sup>11</sup>C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum
    Murray, Melissa E., Lowe, Val J., Graff-Radford, Neill R., Liesinger, Amanda M., Cannon, Ashley, Przybelski, Scott A., Rawal, Bhupendra, Parisi, Joseph E., Petersen, Ronald C., Kantarci, Kejal et al. · 2015 · Brain
  9. Sarcopenia and cognitive impairment: A systematic review and meta-analysis
    Tao‐Chun Peng, Wei‐Liang Chen, Li-Wei Wu, Yaw‐Wen Chang, Tung‐Wei Kao · 2019 · Clinical Nutrition
  10. Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study
    Jack, Clifford R, Wiste, Heather J, Weigand, Stephen D, Therneau, Terry M, Knopman, David S, Lowe, Val, Vemuri, Prashanthi, Mielke, Michelle M, Roberts, Rosebud O, Machulda, Mary M et al. · 2017 · The Lancet Neurology
  11. Classification and Prediction of Brain Disorders Using Functional Connectivity: Promising but Challenging
    Yuhui Du, Zening Fu, Vince D. Calhoun · 2018 · Frontiers in Neuroscience
  12. Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis
    Liss, J. L., Seleri Assunção, S., Cummings, J., Atri, A., Geldmacher, D. S., Candela, S. F., Devanand, D. P., Fillit, H. M., Susman, J., Mintzer, J. et al. · 2021 · Journal of Internal Medicine
  13. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging
    Ossenkoppele, Rik, Smith, Ruben, Mattsson-Carlgren, Niklas, Groot, Colin, Leuzy, Antoine, Strandberg, Olof, Palmqvist, Sebastian, Olsson, Tomas, Jögi, Jonas, Stormrud, Erik et al. · 2021 · JAMA Neurology
  14. Alzheimer's disease diagnostics by adaptation of 3D convolutional network
    Ehsan Hosseini-Asl, Robert Keynton, Ayman S El-Baz · 2016 · Proceedings - International Conference on Image Processing
  15. Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial
    Jill K. Morris, Eric D. Vidoni, David Kevin Johnson, Angela R. Van Sciver, Jonathan D. Mahnken, Robyn A. Honea, Heather Wilkins, William Miles Brooks, Sandra A. Billinger, Russell Howard Swerdlow et al. · 2017 · PLoS ONE
  16. A deep CNN based multi-class classification of Alzheimer's disease using MRI
    Ammarah Farooq, Syed Muhammad Anwar, Muhammad Awais, Saad Ur Rehman · 2017 · IEEE International Conference on Imaging Systems and Techniques (IST)
  17. Developing the ATX(N) classification for use across the Alzheimer disease continuum
    Harald Juergen Hampel, Jeffrey L. Cummings, Kaj Blennow, Peng Gao, Clifford R. Jack, Andrea Vergallo · 2021 · Nature Reviews Neurology
  18. Insulin Resistance and Neurodegeneration: Progress towards the Development of New Therapeutics for Alzheimer's Disease
    de la Monte, Suzanne M. · 2017 · Drugs
  19. Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association
    Johnson, Keith A., Minoshima, Satoshi, Bohnen, Nicolaas I., Donohoe, Kevin J., Foster, Norman L., Herscovitch, Peter, Karlawish, Jason H., Rowe, Christopher C., Carrillo, Maria C., Hartley, Dean M. et al. · 2013 · Journal of Nuclear Medicine
  20. Role of Monoamine Oxidase Activity in Alzheimer’s Disease: An Insight into the Therapeutic Potential of Inhibitors
    Tapan Behl, Dapinder Kaur, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Gökhan Zengin, Felicia Liana Andronie-Cioară, Mirela Mărioara Toma, SIMONA GABRIELA BUNGAU, Adrian Gheorghe Bumbu · 2021 · Molecules
  21. Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders
    Ducharme, Simon, Dols, Annemiek, Laforce, Robert, Devenney, Emma, Kumfor, Fiona, van den Stock, Jan, Dallaire-Théroux, Caroline, Seelaar, Harro, Gossink, Flora, Vijverberg, Everard et al. · 2020 · Brain
  22. Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Consensus Conference
    John Edward Morley, John C. Morris, Marla Berg‐Weger, Soo Borson B, Brian D. Carpenter, Natalia del Campo, Bruno Dubois, Keith N. Fargo, L. Jaime Fitten, Joseph Henry Flaherty et al. · 2015 · Journal of the American Medical Directors Association
  23. Prevalence of dementia subtypes in United States Medicare fee‐for‐service beneficiaries, 2011–2013
    Richard Alan Goodman, Kimberly A. Lochner, Madhav Thambisetty, Thomas S. Wingo, Samuel F. Posner, Shari M. Ling · 2016 · Alzheimer s & Dementia
  24. Innovative diagnostic tools for early detection of Alzheimer's disease
    Laske, Christoph, Sohrabi, Hamid R., Frost, Shaun M., López-de-Ipiña, Karmele, Garrard, Peter, Buscema, Massimo, Dauwels, Justin, Soekadar, Surjo R., Mueller, Stephan, Linnemann, Christoph et al. · 2015 · Alzheimer's &amp; Dementia
  25. Cognitive symptoms of Alzheimer’s disease: clinical management and prevention
    Elizabeth Joe, John Matthew Ringman · 2019 · BMJ
  26. New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs
    Salvatore Salomone, Filippo Caraci, Gian Marco Leggio, Julia Fedotova, Filippo Drago · 2011 · British Journal of Clinical Pharmacology
  27. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
    Rik Ossenkoppele, Ruben A Smith, Tomas G. Ohlsson, Olof T. Strandberg, Niklas Mattsson, Philip S. Insel, Sebastian Palmqvist, Oskar Hansson · 2019 · Neurology
  28. The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions
    S. Johnson, R. Koscik, E. Jonaitis, Lindsay R. Clark, K. Mueller, Sara E. Berman, B. Bendlin, C. Engelman, O. Okonkwo, K. Hogan et al. · 2017 · bioRxiv
  29. Advances in the prevention of Alzheimer's disease and dementia
    Alina Solomon, Francesca Mangialasche, Edo Richard, Sandrine Andrieu, Derrick Bennett, Monique M.B. Breteler, Laura Fratiglioni, Babak Hooshmand, Ara S. Khachaturian, Lon S. S. Schneider et al. · 2014 · Journal of Internal Medicine
  30. Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD
    Rabinovici, G.D., Rosen, H.J., Alkalay, A., Kornak, J., Furst, A.J., Agarwal, N., Mormino, E.C., O'Neil, J.P., Janabi, M., Karydas, A. et al. · 2011 · Neurology
  31. Plasma Amyloid as Prescreener for the Earliest <scp>A</scp> lzheimer Pathological Changes
    Verberk, Inge M. W., Slot, Rosalinde E., Verfaillie, Sander C. J., Heijst, Hans, Prins, Niels D., van Berckel, Bart N. M., Scheltens, Philip, Teunissen, Charlotte E., van der Flier, Wiesje M. · 2018 · Annals of Neurology
  32. A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia
    Pasquale Anthony Della Rosa, Chiara Cerami, Francesca Gallivanone, Annapaola Prestia, Anna Caroli, Isabella Castiglioni, Maria Carla Gilardi, Giovanni Battista Frisoni, Karl John Friston, John Ashburner et al. · 2014 · Neuroinformatics
  33. Mouse models of Alzheimer's disease
    Hall, Alicia M., Roberson, Erik D. · 2012 · Brain Research Bulletin
  34. The complexity of Alzheimer’s disease: an evolving puzzle
    Camilla Ferrari, Sandro Sorbi · 2021 · Physiological Reviews
  35. Prevalence of biologically vs clinically defined alzheimer spectrum entities using the National Institute on Aging–Alzheimer's Association Research Framework
    Jack, Clifford R., Therneau, Terry M., Weigand, Stephen D., Wiste, Heather J., Knopman, David S., Vemuri, Prashanthi, Lowe, Val J., Mielke, Michelle M., Roberts, Rosebud O., Machulda, Mary M. et al. · 2019 · JAMA Neurology
  36. Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients
    Petra Steinacker, Emily Feneberg, Jochen Hans Weishaupt, Johannes Brettschneider, Hayrettin Tumani, Peter Munch Andersen, Christine A. F. Von Arnim, Sarah Böhm, Jan Kassubek, Christian Kubisch et al. · 2015 · Journal of Neurology Neurosurgery & Psychiatry
  37. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials
    Michael Walter Weiner, Dallas P. Veitch, Paul S. S. Aisen, Laurel A. Beckett, Nigel J. Cairns, Robert C. Green, Danielle Jenine Harvey, Clifford R. Jack, William J. Jagust, John C. Morris et al. · 2017 · Alzheimer s & Dementia
  38. Aducanumab: Appropriate Use Recommendations
    Cummings, Jeffrey, Aisen, P., Apostolova, L.G., Atri, A., Salloway, S., Weiner, M. · 2021 · The Journal of Prevention of Alzheimer's Disease
  39. Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study
    David S. Knopman, Rebecca F. Gottesman, Albert Richey Sharrett, Lisa Miller Wruck, Beverly Gwen Windham, Laura H. Coker, Andrea L.C. Schneider, Hengrui Sun, Álvaro Alonso, Josef Coresh et al. · 2016 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  40. Solving neurodegeneration: common mechanisms and strategies for new treatments
    Wareham, Lauren K., Liddelow, Shane A., Temple, Sally, Benowitz, Larry I., Di Polo, Adriana, Wellington, Cheryl, Goldberg, Jeffrey L., He, Zhigang, Duan, Xin, Bu, Guojun et al. · 2022 · Molecular Neurodegeneration
  41. Two phase 3 trials of gantenerumab in early Alzheimer's disease
    Bateman, Randall J., Smith, Janice, Donohue, Michael C., Delmar, Paul, Abbas, Rachid, Salloway, Stephen, Wojtowicz, Jakub, Blennow, Kaj, Bittner, Tobias, Black, Sandra E. et al. · 2023 · New England Journal of Medicine
  42. Social relationships and cognitive decline: A systematic review and meta-analysis of longitudinal cohort studies
    Kuiper, Jisca S., Zuidersma, Marij, Zuidema, Sytse U., Burgerhof, Johannes G. M., Stolk, Ronald P, Oude Voshaar, Richard C., Smidt, Nynke · 2016 · International Journal of Epidemiology
  43. Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
    Bruno Fonseca‐Santos, Marlus Chorilli, Maria Palmira Daflon Gremião · 2015 · International Journal of Nanomedicine
  44. Neuropsychological Measures that Predict Progression from Mild Cognitive Impairment to Alzheimer's type dementia in Older Adults: a Systematic Review and Meta-Analysis
    Sylvie Belleville, Céline Fouquet, Carol Hudon, Hervé Tchala Vignon Zomahoun, Jordie Croteau · 2017 · Neuropsychology Review
  45. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
    Piotr Lewczuk, Peter Franz Riederer, Sid E. O’Bryant, Marcel M. Verbeek, Bruno Dubois, Pieter Jelle Visser, K. A. Jellinger, Sebastiaan Engelborghs, Alfredo Ramı́rez, Lucilla Parnetti et al. · 2017 · The World Journal of Biological Psychiatry
  46. Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
    Piotr Lewczuk, Natalia Ermann, Ulf Andréasson, Christian Schultheis, Jana Podhorná, Philipp Spitzer, Juan Manuel Maler, Johannes Kornhuber, Kaj Blennow, Henrik Zetterberg · 2018 · Alzheimer s Research & Therapy
  47. Clinical aspects of Alzheimer's disease
    Martina Zvěřová · 2019 · Clinical Biochemistry
  48. Brain aging, Alzheimer's disease, and mitochondria
    Swerdlow, Russell H. · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  49. In vivo measurement of widespread synaptic loss in Alzheimer’s disease with SV2A PET
    Mecca, Adam P., Chen, Ming‐Kai, O'Dell, Ryan S., Naganawa, Mika, Toyonaga, Takuya, Godek, Tyler A., Harris, Joanna E., Bartlett, Hugh H., Zhao, Wenzhen, Nabulsi, Nabeel B. et al. · 2020 · Alzheimer's &amp; Dementia
  50. Suspected non-Alzheimer disease pathophysiology — concept and controversy
    Clifford R. Jack, David S. Knopman, Gaël Chételat, Dennis W. Dickson, Anne M. Fagan, Giovanni Battista Frisoni, William J. Jagust, Elizabeth C. Mormino, Ronald Carl Petersen, Reisa Anne Sperling et al. · 2016 · Nature Reviews Neurology
  51. EFNS‐ENS Guidelines on the diagnosis and management of disorders associated with dementia
    Sandro Sorbi, Jakub Hort, Timo Erkinjuntti, Tormod Fladby, Guido Gainotti, Hakan I. Gurvit, Benedetta Nacmias, Florence Pasquier, Bogdan Ovidiu Popescu, Irena Rektorová et al. · 2012 · European Journal of Neurology
  52. Machine learning methods for predicting progression from mild cognitive impairment to Alzheimer’s disease dementia: a systematic review
    Grueso, Sergio, Viejo-Sobera, Raquel · 2021 · Alzheimer's Research &amp; Therapy
  53. Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion
    Eric Westman, J‐Sebastian Muehlboeck, Andrew Simmons · 2012 · NeuroImage
  54. The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?
    Flora Hillegonde Duits, Charlotte Elisabeth Teunissen, Femke H. Bouwman, Pieter Jelle Visser, Niklas Mattsson, Henrik Zetterberg, Kaj Blennow, Oskar Hansson, Lennart Minthon, Niels Andreasen et al. · 2014 · Alzheimer s & Dementia
  55. Recruitment and retention of underrepresented populations in Alzheimer's disease research: A systematic review
    Andrea L Gilmore‐Bykovskyi, Yuanyuan Jin, Carey Elizabeth Gleason, Susan Flowers Benton, Laura Block, Peggye Dilworth‐Anderson, Lisa Laverne Barnes, Manish N. Shah, Megan L. Zuelsdorff · 2019 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  56. Blood‐brain barrier breakdown, neuroinflammation, and cognitive decline in older adults
    Gene L. Bowman, Loı̈c Dayon, Richard E. Kirkland, Jérôme Wojcik, Gwendoline Peyratout, India C. Severin, Hugues Henry, Aikaterini Oikonomidi, Eugenia Migliavacca, Michael Bacher et al. · 2018 · Alzheimer s & Dementia
  57. The Multidisciplinary Approach to Alzheimer’s Disease and Dementia. A Narrative Review of Non-Pharmacological Treatment
    Zucchella, Chiara, Sinforiani, Elena, Tamburin, Stefano, Federico, Angela, Mantovani, Elisa, Bernini, Sara, Casale, Roberto, Bartolo, Michelangelo · 2018 · Frontiers in Neurology
  58. Identifying and Mapping Connectivity Patterns of Brain Network Hubs in Alzheimer's Disease
    Zhengjia Dai, Chao‐Gan Yan, Kuncheng Li, Zhi­qun Wang, Jinhui Wang, Miao Cao, Qixiang Lin, Ni Shu, Mingrui Xia, Yanchao Bi et al. · 2014 · Cerebral Cortex
  59. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
    Niklas Mattsson, Philip S. Insel, Sebastian Palmqvist, Erik Portelius, Henrik Zetterberg, Michael Walter Weiner, Kaj Blennow, Oskar Hansson, the Alzheimer's Disease Neuroimaging Initiative · 2016 · EMBO Molecular Medicine
  60. Biomarkers for Alzheimer's Disease Diagnosis
    Mantzavinos Vasileios, Athanasios T. Alexiou · 2017 · Current Alzheimer Research
  61. Preclinical Alzheimer disease—the challenges ahead
    Sperling, Reisa A., Karlawish, Jason, Johnson, Keith A. · 2013 · Nature Reviews Neurology
  62. Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
    Bader, Jakob M, Geyer, Philipp E, Müller, Johannes B, Strauss, Maximilian T, Koch, Manja, Leypoldt, Frank, Koertvelyessy, Peter, Bittner, Daniel, Schipke, Carola G, Incesoy, Enise I et al. · 2020 · Molecular Systems Biology
  63. Diagnosis of Alzheimer’s Disease via Multi-Modality 3D Convolutional Neural Network
    Yechong Huang, Jiahang Xu, Yuncheng Zhou, Tong Tong, Xiahai Zhuang, the Alzheimer’s Disease Neuroimaging Initiative (ADNI) · 2019 · Frontiers in Neuroscience
  64. Executive Functions in Alzheimer Disease: A Systematic Review
    Guarino, Angela, Favieri, Francesca, Boncompagni, Ilaria, Agostini, Francesca, Cantone, Micaela, Casagrande, Maria · 2019 · Frontiers in Aging Neuroscience
  65. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease
    Shu‐Yi Huang, Ya-Ru Zhang, Yu Guo, Jing Du, Peng Ren, Bang‐Sheng Wu, Jianfeng Feng, Alzheimer’s Disease Neuroimaging Initiative, Wei Cheng, Jin‐Tai Yu · 2024 · Alzheimer s & Dementia
  66. Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia
    La Joie, Renaud, Perrotin, Audrey, de La Sayette, Vincent, Egret, Stéphanie, Doeuvre, Loïc, Belliard, Serge, Eustache, Francis, Desgranges, Béatrice, Chételat, Gaël · 2013 · NeuroImage: Clinical
  67. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer’s disease
    Thal, Dietmar Rudolf, Walter, Jochen, Saido, Takaomi C., Fändrich, Marcus · 2015 · Acta Neuropathologica
  68. Monoaminergic neuropathology in Alzheimer’s disease
    Goran Šimić, Mirjana Babić Leko, Selina Wray, Charles R. Harrington, Ivana Delalle, Nataša Jovanov Milošević, Danira Bažadona, Luc Buée, Rohan de Silva, Giuseppe Di Giovanni et al. · 2016 · Progress in Neurobiology
  69. The amyloid cascade hypothesis: an updated critical review
    Kasper P. Kepp, Nikolaos K. R K Robakis, Poul Flemming Høilund‐Carlsen, Stefano Luca Sensi, Bryce Vissel · 2023 · Brain
  70. Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta‐analyses
    Vanesa Bellou, Lazaros Belbasis, Ioanna Tzoulaki, Lefkos T. Middleton, John P. A. Ioannidis, Εvangelos Εvangelou · 2016 · Alzheimer s & Dementia
  71. Glial activation and inflammation along the Alzheimer’s disease continuum
    Nordengen, Kaja, Kirsebom, Bjørn-Eivind, Henjum, Kristi, Selnes, Per, Gísladóttir, Berglind, Wettergreen, Marianne, Torsetnes, Silje Bøen, Grøntvedt, Gøril Rolfseng, Waterloo, Knut K., Aarsland, Dag et al. · 2019 · Journal of Neuroinflammation
  72. Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature
    Nicolaas Ida Bohnen, David Djang, Karl Herholz, Yoshimi Anzai, Satoshi Minoshima · 2011 · Journal of Nuclear Medicine
  73. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease
    Spina, Salvatore, La Joie, Renaud, Petersen, Cathrine, Nolan, Amber L, Cuevas, Deion, Cosme, Celica, Hepker, Mackenzie, Hwang, Ji-Hye, Miller, Zachary A, Huang, Eric J et al. · 2021 · Brain
  74. Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
    Kelly, Sarah C., He, Bin, Perez, Sylvia E., Ginsberg, Stephen D., Mufson, Elliott J., Counts, Scott E. · 2017 · Acta Neuropathologica Communications
  75. Improving dementia care: The role of screening and detection of cognitive impairment
    Soo Borson B, Lori B. Frank, Peter J. Bayley, Malaz A. Boustani, Marge Dean, Pei‐Jung Lin, John Riley McCarten, John C. Morris, David P. Salmon, Frederick A. Schmitt et al. · 2013 · Alzheimer s & Dementia
  76. Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond
    Elise Cuyvers, Kristel Sleegers · 2016 · The Lancet Neurology
  77. Association of In Vivo [ 18 F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease
    Chenjie Xia, Sara J. Makaretz, Christina Caso, Scott M. McGinnis, Stephen N. Gomperts, Jorge Sepulcre, Teresa Gómez‐Isla, Bradley T. Hyman, Aaron P. Schultz, Neil Vasdev et al. · 2017 · JAMA Neurology
  78. Advances in developing novel therapeutic strategies for Alzheimer’s disease
    Jiqing Cao, Jianwei Hou, Jing Ping, Dongming Cai · 2018 · Molecular Neurodegeneration
  79. Subjective Cognitive Impairment and Affective Symptoms: A Systematic Review
    Hill, Nikki L., Mogle, Jacqueline, Wion, Rachel, Munoz, Elizabeth, DePasquale, Nicole, Yevchak, Andrea M., Parisi, Jeanine M. · 2016 · The Gerontologist
  80. The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures
    Dale S. Sherman, Justin Mauser, Miriam A. Nuno, Dean Sherzai · 2017 · Neuropsychology Review
  81. Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer's disease
    Ansab Akhtar, Sangeeta Pilkhwal Sah · 2020 · Neurochemistry International
  82. Hippocampal neurogenesis: Learning to remember
    Orly Lazarov, Carolyn Hollands · 2016 · Progress in Neurobiology
  83. Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
    Hampel, Harald, Hu, Yan, Cummings, Jeffrey, Mattke, Soeren, Iwatsubo, Takeshi, Nakamura, Akinori, Vellas, Bruno, O’Bryant, Sid, Shaw, Leslie M., Cho, Min et al. · 2023 · Neuron
  84. Diagnostic neuroimaging across diseases
    Klöppel, Stefan, Abdulkadir, Ahmed, Jack, Clifford R., Koutsouleris, Nikolaos, Mourão-Miranda, Janaina, Vemuri, Prashanthi · 2012 · NeuroImage
  85. Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
    Verberk, Inge M. W., Thijssen, Elisabeth, Koelewijn, Jannet, Mauroo, Kimberley, Vanbrabant, Jeroen, de Wilde, Arno, Zwan, Marissa D., Verfaillie, Sander C. J., Ossenkoppele, Rik, Barkhof, Frederik et al. · 2020 · Alzheimer's Research &amp; Therapy
  86. Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease
    Shaw, Leslie M., Arias, Jalayne, Blennow, Kaj, Galasko, Douglas, Molinuevo, Jose Luis, Salloway, Stephen, Schindler, Suzanne, Carrillo, Maria C., Hendrix, James A., Ross, April et al. · 2018 · Alzheimer's &amp; Dementia
  87. The Mini-Addenbrooke's Cognitive Examination: A New Assessment Tool for Dementia
    Sharpley Hsieh, Sarah McGrory, Felicity V. C. Leslie, Kate Dawson, Samrah Ahmed, Christopher Butler, James Benedict Rowe, Eneida Mioshi, John R. Hodges · 2014 · Dementia and Geriatric Cognitive Disorders
  88. Cognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessment
    Noor Kamal Al-Qazzaz, Sawal Hamid Md Ali, Siti Anom Ahmad, Shabiul Islam, Khairiyah Mohamad · 2014 · Neuropsychiatric Disease and Treatment
  89. Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment
    Scheef, Lukas, Spottke, Annika, Daerr, Moritz, Joe, Alexius, Striepens, Nadine, Kölsch, Heike, Popp, Julius, Daamen, Marcel, Gorris, Dominik, Heneka, Michael T. et al. · 2012 · Neurology
  90. Alzheimer’s Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State
    Liang Shen, Lu Liu, Hong‐Fang Ji · 2016 · Journal of Alzheimer s Disease
  91. Evaluation of optical coherence tomography angiographic findings in Alzheimer’s type dementia
    Mehmet Bulut, Fatma Kurtuluş, Onursal Gözkaya, Muhammet Kazım Erol, Ayşe Cengiz Ünal, Melih Akıdan, Aylın Yaman · 2017 · British Journal of Ophthalmology
  92. Brain Amyloid Imaging
    Christopher Cleon Rowe, Victor L. Villemagne · 2011 · Journal of Nuclear Medicine
  93. Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: a systematic review and meta-analysis
    Kingshuk Pal, Naaheed Mukadam, Irene Petersen, Claudia Cooper · 2018 · Social Psychiatry and Psychiatric Epidemiology
  94. Risk Factors for the Progression of Mild Cognitive Impairment to Dementia
    Noll L. Campbell, Fred Unverzagt, Michael A. LaMantia, Babar Ali Khan, Malaz A. Boustani · 2013 · Clinics in Geriatric Medicine
  95. Current state of digital biomarker technologies for real-life, home-based monitoring of cognitive function for mild cognitive impairment to mild Alzheimer disease and implications for clinical care: systematic review
    Piau, Antoine, Wild, Katherine, Mattek, Nora, Kaye, Jeffrey · 2019 · Journal of Medical Internet Research
  96. Olfactory Dysfunction in Neurodegenerative Diseases
    Concepció Marı́n, Dolores Vilas, Cristóbal Langdon, Isam Alobid, Mauricio López‐Chacon, Antje Haehner, Thomas R. Hummel, Joaquim Mullol · 2018 · Current Allergy and Asthma Reports
  97. Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease
    Matthew Taylor, Debra K. Sullivan, Jonathan D. Mahnken, Jeffrey Murray Burns, Russell Howard Swerdlow · 2017 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  98. Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity
    Keith A. Vossel, Kamalini G. Ranasinghe, Alexander J. Beagle, Alice L. La, Kasey Ah Pook, Madelyn R. Castro, Danielle Mizuiri, Susanne M. Honma, Nisha Venkateswaran, MARY E. KOESTLER et al. · 2021 · JAMA Neurology
  99. The Prevalence and Incidence of Dementia Due to Alzheimer’s Disease: a Systematic Review and Meta-Analysis
    Kirsten Marie Fiest, Jodie I. Roberts, Colleen Jean Maxwell, David B. Hogan, Eric Edward Smith, Alexandra D. Frolkis, Adrienne Cohen, Andrew Kirk, Dawn M. Pearson, Tamara Milka Pringsheim et al. · 2016 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  100. Choroid Plexus Volume and Permeability at Brain MRI within the Alzheimer Disease Clinical Spectrum
    Jong Duck Choi, Yeonsil Moon, Hee-Jin Kim, Younghee Yim, Subin Lee, Won‐Jin Moon · 2022 · Radiology